Cannabis News
Market-moving headlines, earnings, and regulatory shifts across the cannabis sector
Track the developments that move cannabis stocks — from quarterly earnings and M&A deals to state-level legalization votes and federal policy changes. Articles are tagged with relevant stock tickers so you can see which companies are affected and jump straight to their market data.
Cannara Biotech Drops 5.1% as Investors Reassess OTC Cannabis Play
LOVFF shares fell to $1.30 amid light trading volume, testing support levels as the Canadian LP faces ongoing market headwinds.
Earth Science Tech Tumbles 5.2% as OTC Cannabis Stock Hits New Lows
ETST shares dropped to $0.11 amid modest trading volume, extending losses from 52-week highs as micro-cap cannabis firm faces market headwinds.
Centr Brands Hovers Near 52-Week Low as CBD Sector Struggles
CNTRF trades at $0.01, just pennies from its 52-week low amid ongoing challenges in the CBD wellness market.
Cannabis Sector Eyes Recovery as 2026 Investment Thesis Takes Shape
Multi-state operators position for federal reform while institutional capital weighs entry points in oversold cannabis equities ahead of potential rescheduling.
Cannabis Allergy Research Opens New Medical Market Opportunities
Emerging research on cannabis and seasonal allergies reveals potential therapeutic applications, creating new product development pathways for medical cannabis companies.
Planet 13 Holdings Surges 5.2% on Strong Trading Volume
PLNHF climbed to $0.91 with above-average volume as the Las Vegas-based cannabis operator continues recovery momentum.
TerrAscend Corp Sees 6.5x Volume Surge as Traders Eye MSO Activity
TSNDF trading volume spiked to 2.03 million shares, dramatically exceeding its 30-day average of 311K amid renewed institutional interest.
Ayurcann Holdings Trades Near Zero as Stock Hits 52-Week Low
AYURF shares trade at virtually zero with minimal volume, highlighting severe distress for the Canadian cannabis processor.
NY Cannabis Showcase Events Launch as Market Expansion Accelerates
New York's Office of Cannabis Management opens applications for temporary cannabis events, creating new revenue streams for licensed operators in the nation's fourth-largest market.
Green Thumb Industries Surges 7% on Strong Volume Movement
GTBIF climbs to $6.56 with 1.2M shares traded, signaling renewed investor confidence in the multi-state operator amid broader cannabis sector momentum.
Decibel Cannabis Co Surges 7.2% on Heavy Trading Volume
DBCCF climbs to $0.09 as trading volume spikes to 39,901 shares, approaching its 52-week high of $0.11.
Verano Holdings Tumbles 8.7% as MSO Faces Market Headwinds
VRNOF drops to $1.26 on elevated volume, highlighting ongoing challenges facing multi-state operators in current market environment.
Senate Split on Cannabis Rescheduling as GOP Resistance Emerges
Bipartisan senators voice mixed reactions to federal cannabis rescheduling, with Democrats pushing for full legalization while Republicans express reservations.
Texas Hemp Ban Faces Legal Roadblock as Industry Fights Restrictions
Texas hemp retailers gain reprieve until July 27 as lawsuit challenges state's smokable product ban, creating regulatory uncertainty for sector operators.
Connecticut Reverses Course on THC Caps, Maintains Cannabis Restrictions
Connecticut lawmakers abandon plan to eliminate THC limits on flower and concentrates, signaling continued regulatory caution in mature East Coast markets.
MariMed Inc (MRMD) Surges 8.1% as Penny Stock Gains Momentum
MariMed Inc rallied 8.1% to $0.08 with elevated volume as the multi-state operator trades near 52-week lows.
Ayr Wellness Plunges 8.6% as MSO Trades Near All-Time Lows
AYRWF shares fell to $0.02 amid elevated volume, highlighting ongoing struggles in the cannabis retail sector.
Israel Moves to Ban Smoked Medical Cannabis in Global Policy Shift
Israel's Health Ministry proposes three-year phase-out of smoked medical cannabis, potentially reshaping global MMJ standards and product development priorities.
Cannabis Rescheduling Creates Market Confusion Amid Mixed Analysis
Acting AG confirms medical marijuana moves to Schedule III, triggering wave of conflicting market interpretations and speculative commentary across industry.
Weed Inc (BUDZ) Surges 9.8% Despite Penny Stock Volatility
Multi-state operator Weed Inc jumped nearly 10% to $0.03 on elevated volume, highlighting the extreme volatility in micro-cap cannabis stocks.